FAM230H: A Drug Target / Disease Biomarker (G100996335)

Target Name: FAM230H

NCBI ID: G100996335

FAM230H

Other Name(s): Family with sequence similarity 230 member H | family with sequence similarity 230 member H

FAM230H: A Drug Target / Disease Biomarker

Fam230H is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 22 and has been shown to be involved in the development and progression of various diseases.

Research has shown that Fam230H is involved in the development of many diseases, including cancer. Studies have shown that when the Fam230H gene is expressed, the cells start to multiply and form tumors. This suggests that Fam230H may be a good target for cancer treatments because by inhibiting its function, researchers can slow down or even stop the growth of cancer cells.

Another study found that Fam230H may be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. The study showed that when the Fam230H gene was expressed in mouse models of these diseases, the mice showed symptoms similar to those seen in humans. This suggests that Fam230H may be a good candidate for treatments for these diseases.

Fam230H has also been shown to be involved in the development of other diseases, including cardiovascular disease and autoimmune disorders. These studies suggest that Fam230H may be a potential drug target or biomarker for a wide range of diseases.

In conclusion, Fam230H is a gene that has been identified as a potential drug target or biomarker for the treatment of many diseases. Further research is needed to fully understand its role in the development and progression of these diseases. If its function is found to be involved in the development of cancer, neurodegenerative diseases and cardiovascular disease, it may be a valuable target for drug development in the future.

Protein Name: Family With Sequence Similarity 230 Member H

The "FAM230H Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM230H comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets